Intracardiac vs. transesophageal echocardiography guided transcatheter closure of patent foramen ovale and atrial septal defects
Transcatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) guidance, but data comparing both modalities in contemporary practice is lacking. Using ICD-10 codes, patients who u...
Saved in:
| Published in: | Cardiovascular revascularization medicine Vol. 77; pp. 61 - 65 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Elsevier Inc
01.08.2025
|
| Subjects: | |
| ISSN: | 1553-8389, 1878-0938, 1878-0938 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Transcatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) guidance, but data comparing both modalities in contemporary practice is lacking. Using ICD-10 codes, patients who underwent transcatheter ASD/PFO closure between 2016 and 2020 using ICE or TEE in the Nationwide Readmissions Database (NRD) were identified. Propensity-score matching was performed to compare in-hospital adverse events, length of stay (LOS), cost, and 30-day non-elective readmissions. A total of 964 patients underwent ASD/PFO closure with ICE (38.3 %, n = 369) or TEE (61.7 %, n = 595) between 2016 and 2020. Propensity score matching yielded 327 patients in each group, which were well balanced. Median (IQR) age was 59.0 (46.0, 72.0) years and 54.7 % were female. No difference was observed in the rate of in-hospital major adverse events between groups. ICE guidance was associated with a lower median cost (ICE $20,140.1 (14,622.3, 25,027.0) vs TEE $20,740.4 (14,137.5, 33,045.3), p < 0.04). In conclusion, ICE guided ASD/PFO closure was associated with lower hospitalization cost without increasing in-hospital adverse events when compared with TEE guidance.
•ICE-guided transcatheter PFO/ASD closures had a safety profile similar to TEE guidance within the context of measured adverse outcomes.•Both ICE and TEE had similarly low rates of in-hospital adverse events, but costs were less with ICE.•These results are reassuring and support the adoption of ICE as a primary imaging modality for transcatheter PFO/ASD closures. |
|---|---|
| AbstractList | Transcatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) guidance, but data comparing both modalities in contemporary practice is lacking. Using ICD-10 codes, patients who underwent transcatheter ASD/PFO closure between 2016 and 2020 using ICE or TEE in the Nationwide Readmissions Database (NRD) were identified. Propensity-score matching was performed to compare in-hospital adverse events, length of stay (LOS), cost, and 30-day non-elective readmissions. A total of 964 patients underwent ASD/PFO closure with ICE (38.3 %, n = 369) or TEE (61.7 %, n = 595) between 2016 and 2020. Propensity score matching yielded 327 patients in each group, which were well balanced. Median (IQR) age was 59.0 (46.0, 72.0) years and 54.7 % were female. No difference was observed in the rate of in-hospital major adverse events between groups. ICE guidance was associated with a lower median cost (ICE $20,140.1 (14,622.3, 25,027.0) vs TEE $20,740.4 (14,137.5, 33,045.3), p < 0.04). In conclusion, ICE guided ASD/PFO closure was associated with lower hospitalization cost without increasing in-hospital adverse events when compared with TEE guidance. Transcatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) guidance, but data comparing both modalities in contemporary practice is lacking. Using ICD-10 codes, patients who underwent transcatheter ASD/PFO closure between 2016 and 2020 using ICE or TEE in the Nationwide Readmissions Database (NRD) were identified. Propensity-score matching was performed to compare in-hospital adverse events, length of stay (LOS), cost, and 30-day non-elective readmissions. A total of 964 patients underwent ASD/PFO closure with ICE (38.3 %, n = 369) or TEE (61.7 %, n = 595) between 2016 and 2020. Propensity score matching yielded 327 patients in each group, which were well balanced. Median (IQR) age was 59.0 (46.0, 72.0) years and 54.7 % were female. No difference was observed in the rate of in-hospital major adverse events between groups. ICE guidance was associated with a lower median cost (ICE $20,140.1 (14,622.3, 25,027.0) vs TEE $20,740.4 (14,137.5, 33,045.3), p < 0.04). In conclusion, ICE guided ASD/PFO closure was associated with lower hospitalization cost without increasing in-hospital adverse events when compared with TEE guidance. •ICE-guided transcatheter PFO/ASD closures had a safety profile similar to TEE guidance within the context of measured adverse outcomes.•Both ICE and TEE had similarly low rates of in-hospital adverse events, but costs were less with ICE.•These results are reassuring and support the adoption of ICE as a primary imaging modality for transcatheter PFO/ASD closures. Transcatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) guidance, but data comparing both modalities in contemporary practice is lacking. Using ICD-10 codes, patients who underwent transcatheter ASD/PFO closure between 2016 and 2020 using ICE or TEE in the Nationwide Readmissions Database (NRD) were identified. Propensity-score matching was performed to compare in-hospital adverse events, length of stay (LOS), cost, and 30-day non-elective readmissions. A total of 964 patients underwent ASD/PFO closure with ICE (38.3 %, n = 369) or TEE (61.7 %, n = 595) between 2016 and 2020. Propensity score matching yielded 327 patients in each group, which were well balanced. Median (IQR) age was 59.0 (46.0, 72.0) years and 54.7 % were female. No difference was observed in the rate of in-hospital major adverse events between groups. ICE guidance was associated with a lower median cost (ICE $20,140.1 (14,622.3, 25,027.0) vs TEE $20,740.4 (14,137.5, 33,045.3), p < 0.04). In conclusion, ICE guided ASD/PFO closure was associated with lower hospitalization cost without increasing in-hospital adverse events when compared with TEE guidance.Transcatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) guidance, but data comparing both modalities in contemporary practice is lacking. Using ICD-10 codes, patients who underwent transcatheter ASD/PFO closure between 2016 and 2020 using ICE or TEE in the Nationwide Readmissions Database (NRD) were identified. Propensity-score matching was performed to compare in-hospital adverse events, length of stay (LOS), cost, and 30-day non-elective readmissions. A total of 964 patients underwent ASD/PFO closure with ICE (38.3 %, n = 369) or TEE (61.7 %, n = 595) between 2016 and 2020. Propensity score matching yielded 327 patients in each group, which were well balanced. Median (IQR) age was 59.0 (46.0, 72.0) years and 54.7 % were female. No difference was observed in the rate of in-hospital major adverse events between groups. ICE guidance was associated with a lower median cost (ICE $20,140.1 (14,622.3, 25,027.0) vs TEE $20,740.4 (14,137.5, 33,045.3), p < 0.04). In conclusion, ICE guided ASD/PFO closure was associated with lower hospitalization cost without increasing in-hospital adverse events when compared with TEE guidance. AbstractTranscatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or intracardiac echocardiography (ICE) guidance, but data comparing both modalities in contemporary practice is lacking. Using ICD-10 codes, patients who underwent transcatheter ASD/PFO closure between 2016 and 2020 using ICE or TEE in the Nationwide Readmissions Database (NRD) were identified. Propensity-score matching was performed to compare in-hospital adverse events, length of stay (LOS), cost, and 30-day non-elective readmissions. A total of 964 patients underwent ASD/PFO closure with ICE (38.3 %, n = 369) or TEE (61.7 %, n = 595) between 2016 and 2020. Propensity score matching yielded 327 patients in each group, which were well balanced. Median (IQR) age was 59.0 (46.0, 72.0) years and 54.7 % were female. No difference was observed in the rate of in-hospital major adverse events between groups. ICE guidance was associated with a lower median cost (ICE $20,140.1 (14,622.3, 25,027.0) vs TEE $20,740.4 (14,137.5, 33,045.3), p < 0.04). In conclusion, ICE guided ASD/PFO closure was associated with lower hospitalization cost without increasing in-hospital adverse events when compared with TEE guidance. |
| Author | Shatla, Islam Huded, Chetan P. Huber, Kenneth Christopher Lehenbauer, Kyle Kennedy, Kevin Magalski, Anthony Saxon, John Thomas Chhatriwalla, Adnan K. Abdelkarim, Islam |
| Author_xml | – sequence: 1 givenname: Islam surname: Shatla fullname: Shatla, Islam email: ishatla@kumc.edu organization: Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, USA – sequence: 2 givenname: Kevin surname: Kennedy fullname: Kennedy, Kevin organization: Division of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA – sequence: 3 givenname: John Thomas surname: Saxon fullname: Saxon, John Thomas organization: Division of Cardiovascular Disease, University of Virginia Health System, Charlottesville, VA, USA – sequence: 4 givenname: Adnan K. surname: Chhatriwalla fullname: Chhatriwalla, Adnan K. organization: Division of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA – sequence: 5 givenname: Anthony surname: Magalski fullname: Magalski, Anthony organization: Division of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA – sequence: 6 givenname: Kyle surname: Lehenbauer fullname: Lehenbauer, Kyle organization: Division of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA – sequence: 7 givenname: Islam surname: Abdelkarim fullname: Abdelkarim, Islam organization: Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, USA – sequence: 8 givenname: Kenneth Christopher surname: Huber fullname: Huber, Kenneth Christopher organization: Division of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA – sequence: 9 givenname: Chetan P. surname: Huded fullname: Huded, Chetan P. organization: Division of Cardiovascular Disease, Saint Luke's Mid America Heart Institute, Kansas City, MO, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39370363$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVUkuL1TAYLTLiPPQfiGTppjWPtmlEhGHwMTDgQl2Hr-nXe3PtTWqSXrg7f7qpd3QhyODqe-ScEzjnuyzOnHdYFM8ZrRhl7atdZSAEPFSc8rqiqsrLR8UF62RXUiW6s9w3jSg70anz4jLGHaVC8lY-Kc6FEpKKVlwUP25dCpCVBguGHGJF8ugiRj9vYYMwETRb_-vdbwLM2yPZLHbA4YQzkLaYMBAz-bgEJH4kMyR0iYw-wB4d8QeYkIAbCKRgs2DEOeUy4IgmxafF4xGmiM_u61Xx9f27Lzcfy7tPH25vru9KUwvWlqpXPQfRcCPNCLQTMNC2Fb3iaDhDOahGMSn7Xqi-gaZjJuvXYuyxyxzsxVXx8qQ7B_99wZj03kaD0wQO_RK1YEzIuuUNz9AX99Cl3-Og52D3EI76t2sZUJ8AJvgYA45_IIzqNRy906dw9BqOpkrnZaa9_otmbIJk_RqBnR4ivz2RMZt0sBh0NBadwcGG7KMevP1fATNZZw1M3_CIceeX4HIAmunINdWf1-NZb4fXlLayXm1582-Bh___Cb342ZE |
| CitedBy_id | crossref_primary_10_15836_ccar2025_175 |
| Cites_doi | 10.1161/STR.0000000000000375 10.1111/j.1540-8159.1997.tb04244.x 10.1016/j.echo.2015.05.015 10.1056/NEJMoa1707404 10.1111/jce.15251 10.1016/j.jacc.2018.02.046 10.1212/WNL.0000000000009443 10.1056/NEJMoa1705915 10.1161/CIRCULATIONAHA.117.031343 10.1016/j.jcin.2009.02.005 |
| ContentType | Journal Article |
| Copyright | 2024 Published by Elsevier Inc. |
| Copyright_xml | – notice: 2024 – notice: Published by Elsevier Inc. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.carrev.2024.09.016 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1878-0938 |
| EndPage | 65 |
| ExternalDocumentID | 39370363 10_1016_j_carrev_2024_09_016 S1553838924006742 1_s2_0_S1553838924006742 |
| Genre | Journal Article Comparative Study |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29B 4.4 457 4G. 53G 5GY 5VS 6PF 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OA~ OL0 OZT P-8 P-9 P2P PC. Q38 ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K Z5R ~G- ~HD 6I. AAFTH AGCQF 9DU AAYXX CITATION AFCTW AGRNS CGR CUY CVF ECM EIF NPM RIG 7X8 |
| ID | FETCH-LOGICAL-c4316-9b9b2a352c7cfa083ad0663b92ec21e7d959177bb39b5a581cdef43fbe852ceb3 |
| ISSN | 1553-8389 1878-0938 |
| IngestDate | Sun Sep 28 10:40:24 EDT 2025 Sun Aug 10 01:31:45 EDT 2025 Tue Nov 18 21:35:25 EST 2025 Sat Nov 29 07:40:44 EST 2025 Sat Sep 06 17:18:57 EDT 2025 Sat Oct 25 09:10:41 EDT 2025 Tue Oct 14 19:33:24 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Atrial septal defect Patent foramen ovale Transesophageal echocardiography Intracardiac echocardiography |
| Language | English |
| License | This is an open access article under the CC BY license. Published by Elsevier Inc. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c4316-9b9b2a352c7cfa083ad0663b92ec21e7d959177bb39b5a581cdef43fbe852ceb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.carrev.2024.09.016 |
| PMID | 39370363 |
| PQID | 3113746252 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_3113746252 pubmed_primary_39370363 crossref_primary_10_1016_j_carrev_2024_09_016 crossref_citationtrail_10_1016_j_carrev_2024_09_016 elsevier_sciencedirect_doi_10_1016_j_carrev_2024_09_016 elsevier_clinicalkeyesjournals_1_s2_0_S1553838924006742 elsevier_clinicalkey_doi_10_1016_j_carrev_2024_09_016 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-08-01 |
| PublicationDateYYYYMMDD | 2025-08-01 |
| PublicationDate_xml | – month: 08 year: 2025 text: 2025-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cardiovascular revascularization medicine |
| PublicationTitleAlternate | Cardiovasc Revasc Med |
| PublicationYear | 2025 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Singh, Badheka, Patel, Chothani, Mehta, Arora (bb0005) 2015; 85 Lee, Song, Kim, Heo, Lee, Kim (bb0020) 2018; 71 Overview of the Nationwide Readmissions Database (NRD). . Mas, Derumeaux, Guillon, Massardier, Hosseini, Mechtouff (bb0010) 2017; 377 Access date: March, 25 Messé SR, Gronseth GS, Kent DM, Kizer JR, Homma S, Rosterman L, Carroll JD, Ishida K, Sangha N, Kasner SE. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the guideline Subcommittee of the American Academy of neurology. Neurology 2020;94:876–885. Kalman, Olgin, Karch, Lesh (bb0060) 1997; 20 Occluder GCS. Transcatheter Septal Occluder. 2023. Newton JD, Mitchell AR, Wilson N, Ormerod OJ. Intracardiac echocardiography for patent foramen ovale closure: justification of routine use. JACC Cardiovasc Interv 2009;2:369; author reply 369–370. Kleindorfer, Towfighi, Chaturvedi, Cockroft, Gutierrez, Lombardi-Hill (bb0035) 2021; 52 Enriquez, Saenz, Rosso, Silvestry, Callans, Marchlinski (bb0045) 2018; 137 Søndergaard, Kasner, Rhodes, Andersen, Iversen, Nielsen-Kudsk (bb0015) 2017; 377 Kaplan, Narang, Gay, Gao, Gibreal, Arora (bb0070) 2021; 32 OCCLUDER AP. Transcatheter Septal Occluder Silvestry, Cohen, Armsby, Burkule, Fleishman, Hijazi (bb0050) 2015; 28 Kleindorfer (10.1016/j.carrev.2024.09.016_bb0035) 2021; 52 Singh (10.1016/j.carrev.2024.09.016_bb0005) 2015; 85 Søndergaard (10.1016/j.carrev.2024.09.016_bb0015) 2017; 377 Lee (10.1016/j.carrev.2024.09.016_bb0020) 2018; 71 10.1016/j.carrev.2024.09.016_bb0040 Enriquez (10.1016/j.carrev.2024.09.016_bb0045) 2018; 137 10.1016/j.carrev.2024.09.016_bb0030 Kaplan (10.1016/j.carrev.2024.09.016_bb0070) 2021; 32 10.1016/j.carrev.2024.09.016_bb0065 10.1016/j.carrev.2024.09.016_bb0055 10.1016/j.carrev.2024.09.016_bb0025 Silvestry (10.1016/j.carrev.2024.09.016_bb0050) 2015; 28 Mas (10.1016/j.carrev.2024.09.016_bb0010) 2017; 377 Kalman (10.1016/j.carrev.2024.09.016_bb0060) 1997; 20 |
| References_xml | – reference: . Access date: March, 25 – reference: OCCLUDER AP. Transcatheter Septal Occluder – reference: , 2023. – volume: 28 start-page: 910 year: 2015 end-page: 958 ident: bb0050 article-title: Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen Ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions publication-title: J Am Soc Echocardiogr – reference: Messé SR, Gronseth GS, Kent DM, Kizer JR, Homma S, Rosterman L, Carroll JD, Ishida K, Sangha N, Kasner SE. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the guideline Subcommittee of the American Academy of neurology. Neurology 2020;94:876–885. – volume: 377 start-page: 1033 year: 2017 end-page: 1042 ident: bb0015 article-title: Patent foramen Ovale closure or antiplatelet therapy for cryptogenic stroke publication-title: N Engl J Med – volume: 137 start-page: 2278 year: 2018 end-page: 2294 ident: bb0045 article-title: Use of Intracardiac echocardiography in interventional cardiology: working with the anatomy rather than fighting it publication-title: Circulation – reference: Occluder GCS. Transcatheter Septal Occluder. – reference: . – reference: Newton JD, Mitchell AR, Wilson N, Ormerod OJ. Intracardiac echocardiography for patent foramen ovale closure: justification of routine use. JACC Cardiovasc Interv 2009;2:369; author reply 369–370. – volume: 85 start-page: 1073 year: 2015 end-page: 1081 ident: bb0005 article-title: Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective publication-title: Catheter Cardiovasc Interv – reference: Overview of the Nationwide Readmissions Database (NRD). – volume: 20 start-page: 2248 year: 1997 end-page: 2262 ident: bb0060 article-title: Use of intracardiac echocardiography in interventional electrophysiology publication-title: Pacing Clin Electrophysiol – volume: 32 start-page: 3117 year: 2021 end-page: 3124 ident: bb0070 article-title: Use of a novel 4D intracardiac echocardiography catheter to guide interventional electrophysiology procedures publication-title: J Cardiovasc Electrophysiol – volume: 377 start-page: 1011 year: 2017 end-page: 1021 ident: bb0010 article-title: Patent foramen Ovale closure or anticoagulation vs. Antiplatelets after stroke publication-title: N Engl J Med – volume: 52 start-page: e364 year: 2021 end-page: e467 ident: bb0035 article-title: 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association publication-title: Stroke – volume: 71 start-page: 2335 year: 2018 end-page: 2342 ident: bb0020 article-title: Cryptogenic stroke and high-risk patent foramen Ovale: the DEFENSE-PFO trial publication-title: J Am Coll Cardiol – volume: 52 start-page: e364 year: 2021 ident: 10.1016/j.carrev.2024.09.016_bb0035 article-title: 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association publication-title: Stroke doi: 10.1161/STR.0000000000000375 – volume: 20 start-page: 2248 year: 1997 ident: 10.1016/j.carrev.2024.09.016_bb0060 article-title: Use of intracardiac echocardiography in interventional electrophysiology publication-title: Pacing Clin Electrophysiol doi: 10.1111/j.1540-8159.1997.tb04244.x – volume: 28 start-page: 910 year: 2015 ident: 10.1016/j.carrev.2024.09.016_bb0050 article-title: Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen Ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions publication-title: J Am Soc Echocardiogr doi: 10.1016/j.echo.2015.05.015 – volume: 85 start-page: 1073 year: 2015 ident: 10.1016/j.carrev.2024.09.016_bb0005 article-title: Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective publication-title: Catheter Cardiovasc Interv – volume: 377 start-page: 1033 year: 2017 ident: 10.1016/j.carrev.2024.09.016_bb0015 article-title: Patent foramen Ovale closure or antiplatelet therapy for cryptogenic stroke publication-title: N Engl J Med doi: 10.1056/NEJMoa1707404 – ident: 10.1016/j.carrev.2024.09.016_bb0025 – volume: 32 start-page: 3117 year: 2021 ident: 10.1016/j.carrev.2024.09.016_bb0070 article-title: Use of a novel 4D intracardiac echocardiography catheter to guide interventional electrophysiology procedures publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.15251 – ident: 10.1016/j.carrev.2024.09.016_bb0030 – volume: 71 start-page: 2335 year: 2018 ident: 10.1016/j.carrev.2024.09.016_bb0020 article-title: Cryptogenic stroke and high-risk patent foramen Ovale: the DEFENSE-PFO trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.02.046 – ident: 10.1016/j.carrev.2024.09.016_bb0040 doi: 10.1212/WNL.0000000000009443 – volume: 377 start-page: 1011 year: 2017 ident: 10.1016/j.carrev.2024.09.016_bb0010 article-title: Patent foramen Ovale closure or anticoagulation vs. Antiplatelets after stroke publication-title: N Engl J Med doi: 10.1056/NEJMoa1705915 – volume: 137 start-page: 2278 year: 2018 ident: 10.1016/j.carrev.2024.09.016_bb0045 article-title: Use of Intracardiac echocardiography in interventional cardiology: working with the anatomy rather than fighting it publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.031343 – ident: 10.1016/j.carrev.2024.09.016_bb0055 – ident: 10.1016/j.carrev.2024.09.016_bb0065 doi: 10.1016/j.jcin.2009.02.005 |
| SSID | ssj0037267 |
| Score | 2.3621104 |
| Snippet | Transcatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or... AbstractTranscatheter closure of atrial septal defects (ASD) and patent foramen ovale (PFO) can be performed with transesophageal echocardiography (TEE) or... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 61 |
| SubjectTerms | Aged Atrial septal defect Cardiac Catheterization - adverse effects Cardiac Catheterization - economics Cardiac Catheterization - instrumentation Cardiovascular Cost Savings Cost-Benefit Analysis Databases, Factual Echocardiography, Transesophageal - adverse effects Echocardiography, Transesophageal - economics Female Foramen Ovale, Patent - diagnostic imaging Foramen Ovale, Patent - economics Foramen Ovale, Patent - therapy Heart Septal Defects, Atrial - diagnostic imaging Heart Septal Defects, Atrial - economics Heart Septal Defects, Atrial - therapy Hospital Costs Humans Intracardiac echocardiography Length of Stay Male Middle Aged Patent foramen ovale Patient Readmission Predictive Value of Tests Retrospective Studies Risk Factors Time Factors Transesophageal echocardiography Treatment Outcome Ultrasonography, Interventional - adverse effects Ultrasonography, Interventional - economics United States |
| Title | Intracardiac vs. transesophageal echocardiography guided transcatheter closure of patent foramen ovale and atrial septal defects |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1553838924006742 https://www.clinicalkey.es/playcontent/1-s2.0-S1553838924006742 https://dx.doi.org/10.1016/j.carrev.2024.09.016 https://www.ncbi.nlm.nih.gov/pubmed/39370363 https://www.proquest.com/docview/3113746252 |
| Volume | 77 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1878-0938 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0037267 issn: 1553-8389 databaseCode: AIEXJ dateStart: 20050101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9swDBbadBh2GfZe9yg0YNilcBE_JR2LIsW6dtmApEBugiwrfSBwsjjJctwv2W8dKclZ2qRodtjFMGRTdsLPIiV9JAn5GDY52CVmgiw1OkgUawYiU0WgdKZznjOjIm2LTbB2m_d64vvW1u86FmY2YGXJ53Mx-q-qhjZQNobO_oO6F51CA5yD0uEIaofjRoo_weVabRWv92fVAVaBKCuD5Qpg7ACNGBjx7HWfrXr_YnpVgN9p77NpXDFxoh4McfHQMqLBH8UUTkMkcoF7CW_rNh2Uq_lRmRGGVBbGUkOW3d2jm2zXsalPffTnytZ-51JNBtaftVhdYw5OwZIvAN1Rc8casASgJbKTJSxc4vv9xJ0COwIWJYxlp8vLHFG6INnVIzPHVMDCpYI5MKttK7bALUtcwzx_jOV8oFOX0jZck3q7_U0en5-dyW6r1_00-hFgVTLcvfclWrbJTsRSwRtk5_Ck1ftS2_qYRbZG8eJF6uBMyyBcffBdzs9dkxvr5HSfkMd-dkIPHaqeki1TPiMPv3olPSe_lsFFAVz0FrjobXBRBy56A1zUg4sO-9SBi3pwUQsuCuCiDlzUgYt6cL0g58et7tHnwNfwCDQmWQhELvJIgZevme4r8PdVgU5uLiKjo9CwQqQiZCzPY5GnKuWhhv6SuJ8bDjImj1-SRjkszWtCMxYluUhNpvo60ZFSLEm5SECCs7iI2S6J6z9Xap_gHuusDGTNZLyWTiUSVSKbQkLjLgkWUiOX4OWe-9Nab7IOXgZzKwF198ixdXKm8kNHJUNZRbIpO1jJi8M8AtndGUuiZUnvFjt3d4NnfqiBJcFq4FagKs1wWsk4DGOWZFEKvb9yiFv8ekyRifSONxtIvyWP_n6s70hjMp6a9-SBnk2uqvEe2WY9vue_mT-MgfdM |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intracardiac+vs.+transesophageal+echocardiography+guided+transcatheter+closure+of+patent+foramen+ovale+and+atrial+septal+defects&rft.jtitle=Cardiovascular+revascularization+medicine&rft.au=Shatla%2C+Islam&rft.au=Kennedy%2C+Kevin&rft.au=Saxon%2C+John+Thomas&rft.au=Chhatriwalla%2C+Adnan+K&rft.date=2025-08-01&rft.issn=1878-0938&rft.eissn=1878-0938&rft_id=info:doi/10.1016%2Fj.carrev.2024.09.016&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15538389%2FS1553838925X00099%2Fcov150h.gif |